Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference7 articles.
1. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease;Naderi;Respir Med,2018
2. Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations;Djamin;Respir Med,2019
3. Management of COPD exacerbations;Evensen;Am Fam Physician,2010
4. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial;Uzun;Lancet Respir Med,2014
5. Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A multicenter, randomized, double-blind, placebo-controlled trial;Vermeersch;Am J Respir Crit Care Med,2019